Safety of enoxaparin versus unfractioned heparin in patients undergoing percutaneous coronary intervention using drug eluting stents: A pilot study

Background: Unfractioned heparin (UFH) is the standard antithrombotic agent in elective percutaneous coronary intervention (PCI), but has its own limitations. Several studies have suggested intravenous enoxaparin as a safe and effective alternative but most of them are uncontrolled. Our main goal wa... Ausführliche Beschreibung

1. Person: MJ Zibaeenezhad verfasserin
Weitere Personen: H kamfiroozi verfasserin; K Aghasadeghi verfasserin
Quelle: In Iranian Cardiovascular Research Journal
Weitere Artikel
Format: Online-Artikel
Genre: Cardiovascular, Medicine (General), Health Sciences
Beschreibung: Online-Ressource
Online Zugang: Online
Online
Online
Online
Volltext
Tags: Hinzufügen
Keine Tags. Fügen Sie den ersten Tag hinzu!
  Creative Commons License Source: Directory of Open Access Journals (DOAJ).
LEADER 02646nma a2200349 c 4500
001 DOAJ017064988
003 DE-601
005 20190329120448.0
007 cr uuu---uuuuu
008 171226nuuuuuuuu 000 0 und d
035 |a (DE-599)DOAJ7ddbaa3f63fe490491ec95587e27ce95 
040 |b ger  |c GBVCP 
100 0 |a MJ Zibaeenezhad  |e verfasserin  |4 aut 
245 1 0 |a Safety of enoxaparin versus unfractioned heparin in patients undergoing percutaneous coronary intervention using drug eluting stents: A pilot study  |h Elektronische Ressource 
300 |a Online-Ressource 
520 |a Background: Unfractioned heparin (UFH) is the standard antithrombotic agent in elective percutaneous coronary intervention (PCI), but has its own limitations. Several studies have suggested intravenous enoxaparin as a safe and effective alternative but most of them are uncontrolled. Our main goal was to evaluate the safety of enoxaparin over UFH in PCI patients undergoing coronary stenting by drug eluting stents (DES).Methods: We randomly assigned 195 patients undergoing PCI using DES to receive either 0.75 mg enoxaparin per kilogram of body weight or 10000 IU unfractioned heparin. The primary end point was the incidence of major or minor bleeding . The secondary end point was the incidence of acute coronary events (ST-elevation myocardial infarction, non ST-elevation myocardial infarction,and unstable angina) in the first 24 hours after PCI.Results: The rate of major and minor bleedings was similar in the first 24 hours after procedure between enoxaparin group and UFH group ( P value>0.05). The incidence of acute coronary events and mortality was also similar between two arms.Conclusion: In DES based PCI , a single intravenous bolus of 0.75 mg of enoxaparin per kilogram is associated with similar rate of bleeding as compaired with UFH. Also the rates of ischemic events are not different for enoxaparin and UFH however larger trials are needed for definit conclusion. 
655 7 |a Cardiovascular  |2 gnd 
655 7 |a Medicine (General)  |2 gnd 
655 7 |a Health Sciences  |2 gnd 
689 0 0 |a Cardiovascular 
689 0 1 |a Medicine (General) 
689 0 2 |a Health Sciences 
689 0 |5 DE-601 
700 0 |a H kamfiroozi  |e verfasserin  |4 aut 
700 0 |a K Aghasadeghi  |e verfasserin  |4 aut 
773 0 8 |i In  |t Iranian Cardiovascular Research Journal  |w (DE-601)DOAJ000029521  |x 1735-885X 
856 4 0 |y DOAJ  |u https://doaj.org/article/7ddbaa3f63fe490491ec95587e27ce95 
856 4 0 |u http://www.icrj.ir/Files/AuthArts/1027+.PDF 
856 4 0 |u https://doaj.org/toc/1735-885X 
856 4 0 |u https://doaj.org/toc/1735-8868 
912 |a GBV_DOAJ 
951 |a AR 

Ähnliche Einträge

Privacy Notice Ask a Librarian New Acquisitions